Northeast Financial Consultants Inc Medtronic PLC Transaction History

Northeast Financial Consultants Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$87.4 - $113.09 $158,543 - $205,145	-1,814 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$100.58 - $112.38 $102,993 - $115,077	-1,024 Reduced 36.08%	1,814 $201,000
Q4 2021 Feb 11, 2022	SELL	$99.53 - $127.75 $23,090 - $29,638	-232 Reduced 7.56%	2,838 $294,000
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $76,473 - $84,210	-623 Reduced 16.87%	3,070 $385,000
Q2 2021 Aug 16, 2021	BUY	$118.19 - $131.5 $70,914 - $78,900	600 Added 19.4%	3,693 $458,000
Q1 2021 May 13, 2021	BUY	$111.18 - $119.74 $25,793 - $27,779	232 Added 8.11%	3,093 $365,000
Q3 2020 Oct 29, 2020	SELL	$90.13 - $108.78 $1,081 - $1,305	-12 Reduced 0.42%	2,861 $297,000
Q2 2020 Jul 30, 2020	BUY	$84.11 - $103.33 $504 - $619	6 Added 0.21%	2,873 $263,000
Q1 2020 May 13, 2020	BUY	$72.92 - $121.3 $437 - $727	6 Added 0.21%	2,867 $259,000
Q4 2019 Feb 14, 2020	SELL	$104.49 - $114.54 $106,475 - $116,716	-1,019 Reduced 26.26%	2,861 $325,000
Q2 2019 Aug 09, 2019	BUY	$84.15 - $99.38 $1,935 - $2,285	23 Added 0.6%	3,880 $378,000
Q1 2019 May 14, 2019	BUY	$82.45 - $93.79 $318,009 - $361,748	3,857 New	3,857 $351,000
Q3 2018 Nov 08, 2018	SELL	$85.91 - $99.17 $222,077 - $256,354	-2,585 Closed	0 $0
Q1 2018 Apr 19, 2018	SELL	$76.55 - $87.26 $20,056 - $22,862	-262 Reduced 9.2%	2,585 $207,000
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $20,155 - $21,877	262 Added 10.14%	2,847 $229,000
Q3 2017 Nov 13, 2017	BUY	$77.71 - $84.6 $200,880 - $218,690	2,585	2,585 $201,000

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.